Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guide Therapeutics, Inc.

https://guidetx.com/

Latest From Guide Therapeutics, Inc.

Prime Medicine Launches With $315m To Fund New Approach To Gene Editing

The company sees its gene-editing technology, which it compares to a DNA “word processor,” as having potentially broad applicability.

Gene Therapy Financing

Pipeline Packed As Cash Pours Into Cell And Gene Therapy Space

Cell, gene and RNA therapies are starting to transform the healthcare landscape and a report from the American Society of Gene + Cell Therapy and Informa Pharma Intelligence maps the progress the sector made in the first quarter of 2021.

Gene Therapy Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Nanotechnology, Chips, etc.
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register